Jump to content
Sign in to follow this  

Former FDA Commission Admits Vax is Useless, Vaccine Stocks Start to Tank

Recommended Posts

Don't get too excited... he's only saying this now that there's a magic pill to replace the magic shot. Inadvertently he reaffirms what many of us have been saying in that therapeutics are the future. I would like to see the ingredients of this pill but I'm sure it's similar to those other therapeutics that were dismissed by the usual loons. Wall St must know something because now everyone but Pfizer is dropping like a rock on the stock market. Looks like they need to dump their inventory into our 5 - 11 year old children to make a fast run at diminishing cash. You can cancel the mandates now Brandon.

Former FDA Commissioner Scott Gottlieb: Pfizer Pill Means Pandemic’s End ‘in Sight


JOE KERNEN: Do you feel that this Pfizer drug has shown better efficacy than the Merck drug, with perhaps less concern about immunogenicity or other side effects?

DR. SCOTT GOTTLIEB: There weren’t comparative trials down. Bottom line is we have an overwhelming tool box right now to combat COVID. This is a phenomenal result. It exceeded any reasonable expectation… I think the bottom line is the end of the pandemic‚ at least as it relates to the United States, is in sight right now — given that we have the tools to combat this disease. Now, we still have to get through this Delta wave. Unfortunately, we’re not going to be able to vaccinate our way out of it. These therapeutics are coming too late to affect that wave of infection. But once we get through this Delta wave of infection over the course of the next two months, I think this therapeutic and other innovations that we’ve seen coming to market really mark the end of the pandemic in the United States.

Pfizer soars 11% on strong results from COVID-19 pill study, while Moderna and Merck tumble


Pfizer stock soared as much as 11% Friday after the drug giant said its COVID-19 pill cuts the risk of severe COVID-19 by 89%.
The strong evidence of the antiviral pill decreasing chances of hospitalization or death for high-risk adults prompted Pfizer to stop the drug trial. The company plans to seek the Food and Drug Administration's OK this month for the pill, with doses potentially ready for delivery this year.
Rival Merck, which is also producing a COVID-19 pill, saw shares fall as much as 10% on Friday. Merck said last month that trial results for it's COVID-19 pill, molnupiravir, showed it halved the risk of hospitalization or death for COVID-19 patients.

Shares of Moderna, which developed a COVID-19 vaccine, tumbled 22% at intraday lows as investors anticipate lower demand for shots. The selloff comes on the heels of Moderna's Thursday announcement of lower than expected earnings and a slashed sales forecast.
BioNTech, which also developed a vaccine with partner Pfizer, sank as much as 20%. BioNTech is set to report earnings next week.
Oral treatments for COVID-19 would be a game-changer, as these would allow patients to be treated at home, different from the current treatments that require a clinical setting and professional administration.

Fast And Furious No Shit GIF by The Fast Saga



  • Thanks 1
  • Haha 1

Sack "The Buffalo Range's TRUSTED News Source!"

“When a well-packaged web of lies has been sold gradually to the masses over generations, the truth will seem utterly preposterous and its speaker a raving lunatic.” ~ Dresden James

Parler @NYexile




Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • Create New...